Free Trial
LON:BTG

BTG (BTG) Share Price, News & Analysis

BTG logo

About BTG Stock (LON:BTG)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
840
840
52-Week Range
N/A
Volume
271,742 shs
Average Volume
960,389 shs
Market Capitalization
£3.26 billion
P/E Ratio
29.47
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

Remove Ads
Receive BTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

BTG Stock News Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
B2Gold price target raised to $4.50 from $3.50 at Raymond James
Arcos Dorados initiated with a Buy at BTG Pactual
See More Headlines

BTG Stock Analysis - Frequently Asked Questions

BTG plc (LON:BTG) issued its earnings results on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, beating the consensus estimate of $29.80 by $3.10.

Shares of BTG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC) and B2Gold (BTO).

Company Calendar

Last Earnings
5/15/2018
Today
4/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Precious Metals
Current Symbol
LON:BTG
CIK
N/A
Fax
N/A
Employees
4,690
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.47
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£914.10 million
Price / Cash Flow
9.25
Book Value
GBX 355.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£3.26 billion
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (LON:BTG) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners